These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 1681028)

  • 81. High prevalence of hepatitis delta virus infection detectable by enzyme immunoassay among apparently healthy individuals in Mongolia.
    Inoue J; Takahashi M; Nishizawa T; Narantuya L; Sakuma M; Kagawa Y; Shimosegawa T; Okamoto H
    J Med Virol; 2005 Jul; 76(3):333-40. PubMed ID: 15902700
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era.
    Maida I; Ríos MJ; Pérez-Saleme L; Ramos B; Soriano V; Pegram PS; Mura MS; Sánchez-Margalet V; Saldívar-Cornejo I; Wilkin A; Babudieri S; Núñez M
    AIDS Res Hum Retroviruses; 2008 May; 24(5):679-83. PubMed ID: 18462085
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Hepatitis delta virus propagation enabled by hepatitis C virus-Scientifically intriguing, but is it relevant to clinical practice?
    Pflüger LS; Schulze Zur Wiesch J; Polywka S; Lütgehetmann M
    J Viral Hepat; 2021 Jan; 28(1):213-216. PubMed ID: 32852870
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Hepatitis B virus clearance from serum and liver after acute hepatitis delta virus superinfection in chronic HBsAg carriers.
    Pastore G; Monno L; Santantonio T; Angarano G; Milella M; Giannelli A; Fiore JR
    J Med Virol; 1990 Aug; 31(4):284-90. PubMed ID: 2269880
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Prevalence of antibody to hepatitis C virus in chronic HBsAg carriers.
    Rodríguez M; Navascues CA; Martínez A; Suárez A; Riestra S; Sala P; González M; Rodrigo L
    Arch Virol Suppl; 1992; 4():327-8. PubMed ID: 1333329
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Hepatitis delta coinfection in persons with HIV: misdiagnosis and disease burden in Italy.
    Brancaccio G; Shanyinde M; Puoti M; Gaeta GB; Monforte AD; Vergori A; Rusconi S; Mazzarelli A; Castagna A; Antinori A; Cozzi-Lepri A;
    Pathog Glob Health; 2023 Mar; 117(2):181-189. PubMed ID: 35249472
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Hepatitis D virus antibody in HBsAg-positive and HBsAg-negative substance abusers with chronic liver disease.
    Novick DM; Farci P; Karayiannis P; Gelb AM; Stenger RJ; Kreek MJ; Thomas HC
    J Med Virol; 1985 Apr; 15(4):351-6. PubMed ID: 3884737
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Persistent delta antigenaemia in chronic delta hepatitis and its relation with human immunodeficiency virus infection.
    Roingeard P; Dubois F; Marcellin P; Bernuau J; Bonduelle S; Benhamou JP; Goudeau A
    J Med Virol; 1992 Nov; 38(3):191-4. PubMed ID: 1287132
    [TBL] [Abstract][Full Text] [Related]  

  • 89. HIV and HBV infection in intravenous drug addicts from northeastern Italy.
    Conte D; Ferroni P; Lorini GP; Aimo GP; Mandelli C; Cesana M; Brunelli L; Bignotti GC; Bianchi PA; Zanetti AR
    J Med Virol; 1987 Aug; 22(4):299-306. PubMed ID: 3498007
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Hepatitis C virus infection in individuals with or without human immunodeficiency virus type 1 infection.
    Sönnerborg A; Abebe A; Strannegård O
    Infection; 1990; 18(6):347-51. PubMed ID: 2127586
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Adaptive Immune Responses, Immune Escape and Immune-Mediated Pathogenesis during HDV Infection.
    Oberhardt V; Hofmann M; Thimme R; Neumann-Haefelin C
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215790
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Increase of the prevalence of hepatitis B virus surface antigen related to immunodeficiency inherent in acquired immune deficiency syndrome (AIDS).
    Ouattara SA; Meite M; Aron Y; Akran V; Gody M; Manlan LK; de-The G
    J Acquir Immune Defic Syndr (1988); 1990; 3(3):282-6. PubMed ID: 2154578
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Epidemiological trends of HBV and HDV coinfection among Viennese HIV+ patients.
    Schmidbauer C; Chromy D; Schmidbauer VU; Schwarz M; Jachs M; Bauer DJM; Binter T; Apata M; Nguyen DT; Mandorfer M; Simbrunner B; Rieger A; Mayer F; Breuer M; Strassl R; Schmidt R; Holzmann H; Trauner M; Gschwantler M; Reiberger T
    Liver Int; 2021 Nov; 41(11):2622-2634. PubMed ID: 34268869
    [TBL] [Abstract][Full Text] [Related]  

  • 94. The balance of type 1 and type 2 immune responses in the contexts of hepatitis B infection and hepatitis D infection.
    Townsend EC; Zhang GY; Ali R; Firke M; Moon MS; Han MAT; Fram B; Glenn JS; Kleiner DE; Koh C; Heller T
    J Gastroenterol Hepatol; 2019 Apr; 34(4):764-775. PubMed ID: 30695096
    [TBL] [Abstract][Full Text] [Related]  

  • 95. The prevalence of HDV among HBsAg-positive populations with and without HIV-1 in China.
    Wang Y; Shen G; Lu R; Liu J; Zhang F; Wang H; Cai W; Zhang F
    Int J Infect Dis; 2024 Mar; 140():70-77. PubMed ID: 38218378
    [TBL] [Abstract][Full Text] [Related]  

  • 96. HBV, HDV and HIV infections in 242 drug addicts: two-year follow-up.
    Mandelli C; Cesana M; Ferroni P; Lorini GP; Aimo GP; Tagger A; Bianchi PA; Conte D
    Eur J Epidemiol; 1988 Sep; 4(3):318-21. PubMed ID: 3181382
    [TBL] [Abstract][Full Text] [Related]  

  • 97. HBsAg subtype distribution among different populations of HBsAg carriers in Spain.
    Echevarría JE; León P; López JA; Tenorio A; Domingo CJ; Echevarría JM
    Eur J Epidemiol; 1995 Feb; 11(1):39-45. PubMed ID: 7489772
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Inhibition of HBV replication during coinfection with HBV and HDV: inhibition of the inhibition by coinfection with HIV.
    Govindarajan S
    Hepatology; 1990 Apr; 11(4):703-4. PubMed ID: 2328961
    [No Abstract]   [Full Text] [Related]  

  • 99. Prevalence of hepatitis B virus, delta agent and human immunodeficiency virus infections in drug addicts.
    Bailly D; Dervaux A; Servant D; Parquet PJ
    Biomed Pharmacother; 1989; 43(6):431-7. PubMed ID: 2686771
    [TBL] [Abstract][Full Text] [Related]  

  • 100. The impact of chronic hepatitis C virus infection on HIV disease and progression in intravenous drug users.
    Haydon GH; Flegg PJ; Blair CS; Brettle RP; Burns SM; Hayes PC
    Eur J Gastroenterol Hepatol; 1998 Jun; 10(6):485-9. PubMed ID: 9855064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.